Figure 3.

Kaplan–Meier estimates effect of genotype in rs33933140 and dosimetric parameters on RP‐free survival (RP ≥ grade 3). (A) rs33933140 and MLD; (B) rs33933140 and V20. Patients with AA genotype of AKT2: rs33933140 and MLD ≥ 15 Gy or V20 ≥ 24% had the highest risk of RP grade ≥ 3 compared with other groups (P < 0.0001 and P < 0.0001, respectively).